Dispirooxindoles Based on 2-Selenoxo-Imidazolidin-4-Ones: Synthesis, Cytotoxicity and ROS Generation Ability.
ROS generation
azomethine ylides
cytotoxicity
indolinones
prooxidant properties
selenohydantoins
spiro compounds
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
05 Mar 2021
05 Mar 2021
Historique:
received:
13
12
2020
revised:
25
02
2021
accepted:
01
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
23
4
2021
Statut:
epublish
Résumé
A regio- and diastereoselective synthesis of two types of dispiro derivatives of 2-selenoxoimidazolidin-4-ones, differing in the position of the nitrogen atom in the central pyrrolidine ring of the spiro-fused system-namely, 2-selenoxodispiro[imidazolidine-4,3'-pyrrolidine-2',3″-indoline]-2″,5-diones (
Identifiants
pubmed: 33807662
pii: ijms22052613
doi: 10.3390/ijms22052613
pmc: PMC7961907
pii:
doi:
Substances chimiques
Cytotoxins
0
Pyrrolidines
0
Reactive Oxygen Species
0
TP53 protein, human
0
Tumor Suppressor Protein p53
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Russian Foundation for Basic Research
ID : 19-03-00201
Organisme : Russian Foundation for Basic Research
ID : 20-33-90008
Organisme : Russian Science Foundation
ID : 19-79-30062
Organisme : Competitiveness Program of NUST "MISIS"
ID : Governmental decree dated March 16, 2013, No. 211
Références
J Med Chem. 2016 Nov 23;59(22):10147-10162
pubmed: 27775892
Sci Rep. 2018 May 10;8(1):7462
pubmed: 29748550
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
J Org Chem. 2020 Jul 17;85(14):9290-9300
pubmed: 32583669
Mol Cancer Ther. 2013 Jan;12(1):3-15
pubmed: 23112250
PLoS One. 2013;8(3):e59380
pubmed: 23555026
Anticancer Drugs. 2011 Sep;22(8):732-40
pubmed: 21562407
Clin Cancer Res. 2004 Apr 1;10(7):2561-9
pubmed: 15073137
Drug Discov Today. 2021 Jan;26(1):256-263
pubmed: 33164821
J Pharm Sci. 1973 Jun;62(6):948-51
pubmed: 4712630
J Med Chem. 2013 Nov 27;56(22):9089-99
pubmed: 24160297
Biochim Biophys Acta. 2015 Aug;1850(8):1642-60
pubmed: 25459512
Nature. 1979 Mar 15;278(5701):261-3
pubmed: 218111
Cell Cycle. 2012 Dec 15;11(24):4579-88
pubmed: 23187804
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
ACS Nano. 2014 Jan 28;8(1):875-84
pubmed: 24377306
J Med Chem. 2020 Nov 12;63(21):13031-13063
pubmed: 32985193
Bioorg Med Chem. 2016 Feb 15;24(4):802-11
pubmed: 26780833
Eur J Med Chem. 2014 Feb 12;73:195-209
pubmed: 24412495
Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6302-7
pubmed: 18424558
J Steroid Biochem. 1979 Jul;11(1A):93-9
pubmed: 385986
Asian Pac J Cancer Prev. 2018 Oct 26;19(10):2877-2884
pubmed: 30362316
ACS Comb Sci. 2019 Jun 10;21(6):456-464
pubmed: 31009196
Antioxid Redox Signal. 2007 Jul;9(7):775-806
pubmed: 17508906
Eur J Med Chem. 2012 Feb;48:143-52
pubmed: 22204902
Mol Carcinog. 1999 Dec;26(4):213-25
pubmed: 10569799
Clin Cancer Res. 2008 Jun 15;14(12):3926-32
pubmed: 18559614
Adv Cancer Res. 2017;136:259-302
pubmed: 29054421
Mol Carcinog. 2000 Dec;29(4):236-50
pubmed: 11170262
Mol Cancer Ther. 2008 May;7(5):1297-308
pubmed: 18483317
Bioorg Med Chem Lett. 2016 Mar 15;26(6):1558-1560
pubmed: 26883150
J Am Chem Soc. 2005 Jul 27;127(29):10130-1
pubmed: 16028899
Curr Med Chem. 2012;19(18):3031-43
pubmed: 22455594
Angew Chem Int Ed Engl. 2003 Oct 13;42(39):4742-58
pubmed: 14562341
Bioorg Med Chem Lett. 2015 Jan 15;25(2):404-9
pubmed: 25479770
Bioorg Chem. 2019 Feb;82:74-85
pubmed: 30273836
Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11788-93
pubmed: 22745160
Br J Cancer. 2014 Apr 2;110(7):1733-43
pubmed: 24619073